About Gene List

PF3D7_0603300 (DHODH)

Genome location: Pf3D7_06_v3:130,191..132,792(-)

Genome classification: Core

Function and Localization

Product Description: dihydroorotate dehydrogenase

SignalP Peptide: N/A

# Transmembrane Domains: 1

EC Numbers: 1.3.5.2 (Dihydroorotate dehydrogenase (quinone))

Curated GO (PlasmoDB):

Type GO Term Name
Component GO:0005743 mitochondrial inner membrane
Component GO:0005739 mitochondrion
Function GO:0004152 dihydroorotate dehydrogenase activity
Process GO:0006207 'de novo' pyrimidine nucleobase biosynthetic process
Process GO:0009220 pyrimidine ribonucleotide biosynthetic process
Process GO:0042493 response to drug
Process GO:0009410 response to xenobiotic stimulus

Expression by stage (LR - Le Roch et al., and MCA - Malaria Cell Atlas):

Stage LR class MCA mean MCA prop. zeros
Sporozoite not expressed N/A N/A
Ring expressed 0.20 0.90
Trophozoite expressed 0.57 0.69
Schizont expressed 0.07 0.96
Gametocyte possibly expressed 0.15 0.91

More info:

Resistome Mutations

Old (Pf3D7v3) Gene ID: PF3D7_0603300

Resistome Missense Mutations: F188I, F227Y, F227L, I263S, C276Y, L531F, L531F

Resistome Compounds with Missense Mutations: DSM265, DSM267, MMV1454442, TCMDC-125334

Resistome # Samples with Disruptive Mutations: 18 (18 missense, 15 "interesting" missense)

Essentiality (ABS)

Zhang Phenotype: Non - Mutable in CDS

MIS: 0.125 | MFS: -3.099 | #Insertions: 0

PlasmoGEM Phenotype: Slow (Pb ortholog: PBANKA_0102100)

  • Relative Growth Rate: 0.20 ± 0.08
  • Confidence: 6.37

RMgmDB ABS Phenotype: Different from wild type (Pb ortholog: PBANKA_0102100)

Modification: Disrupted | RMgm-1610

More info: PhenoPlasm Link

Binding Evidence

AlphaFill Uniprot ID: Q08210

"Best" AlphaFill ligand hit: FOT (5-fluoro-2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid, Local RMSD=0.04) with 3W1A (Global RMSD=1.41)

BRENDA EC Inhibitors:

EC # Name EC Inhibitors
1.3.5.2 dihydroorotate dehydrogenase (quinone) HR325OrotatealloxanredoxalLawsoneMNA 279MNA 715A77 1726LapacholA77-1726menadionebrequinar...

Orthology to BindingDB Entries:

UniProt Protein Name Species Homology Source BindingDB Ligands
Q08210 Dihydroorotate dehydrogenase (quinone), mitochondrial Plasmodium falciparum HOGENOM, OMA, OrthoDB, OrthoMCL, OrthoMCL BLAST tricyclic compound 5tricyclic compound 6bicyclic compound 7monocyclic compound 8...
Q02127 Dihydroorotate dehydrogenase (quinone), mitochondrial Homo sapiens OMA, OrthoDB, OrthoMCL BLAST US8536165, 110tricyclic compound 5TERIFLUNOMIDEBiphenquinate...
A0A509AEH5 Dihydroorotate dehydrogenase (quinone), mitochondrial [100-517] Plasmodium berghei OMA, OrthoDB, OrthoMCL, OrthoMCL BLAST JMC521864 Compund DSM1JMC521864 Compund DSM2cid_741601triazolopyrimidine-based compound, DSM98...
O35435 Dihydroorotate dehydrogenase (quinone), mitochondrial Mus musculus OMA, OrthoDB, OrthoMCL BLAST CHEMBL3289670CHEMBL3289672TERIFLUNOMIDECHEMBL3289671...
Q54A96 Dihydroorotate dehydrogenase (quinone), mitochondrial Plasmodium falciparum OMA, OrthoMCL, OrthoMCL BLAST Asinex compound no. 1ChemBridge compound no. 2ChemBridge compound no. 3Asinex compound no. 4...
G4VFD7 Dihydroorotate dehydrogenase (quinone), mitochondrial OMA, OrthoDB, OrthoMCL, OrthoMCL BLAST CHEMBL4436314CHEMBL4560384ATOVAQUONECHEMBL2408377...
Q63707 Dihydroorotate dehydrogenase (quinone), mitochondrial Rattus norvegicus OrthoDB, OrthoMCL BLAST AtovaquoneBiphenquinateAtovaquoneBiphenquinate...
A5K1N1 Dihydroorotate dehydrogenase (quinone), mitochondrial Plasmodium vivax OrthoMCL, OrthoMCL BLAST US8703811, 2US8703811, 3US8703811, 1US8703811, 5...

Orthology Information

Ortholog Group (OrthoMCL): OG6_101797

Most Similar Human Ortholog: Q02127

TM-align score: 0.91 | RMSD: 2.80

Seq Identity: 0.37 | Length: 389 / 569

All Human Orthologs (OrthoMCL):

Gene ID Description
ENSG00000102967 dihydroorotate dehydrogenase (quinone)

Protein Information

Protein Length: 569 | Molecular Weight (kDa): 65.558

UniProt ID(s): Q08210, Q54A96

PDB ID(s): 1TV5, 3I65, 3I68, 3I6R, 3O8A, 3SFK, 4CQ8, 4CQ9, 4CQA, 4ORM, 4RX0, 5BOO, 5DEL, 5FI8, 5TBO, 6E0B, 6GJG, 6VTY, 7KYK, 7KYV, 7KYY, 7KZ4, 7KZY, 7L01, 7L0K, 7S87

Isoelectric Point: 9.43

Protein Domain Annotations:

Source Family ID Description
InterPro IPR001295 Dihydroorotate dehydrogenase, conserved site
InterPro IPR005719 Dihydroorotate dehydrogenase, class 2
InterPro IPR005720 Dihydroorotate dehydrogenase domain
PFam PF01180 Dihydroorotate dehydrogenase domain
Superfamily SSF51395 N/A

Genetic Variation

MalariaGEN Pf7 (worldwide samples) # unique SNV/indels:

Homozygous genotype calls only

variant type common rare doubleton singleton
synonymous 5 25 11 43
disruptive 4 34 26 58
missense 4 34 26 56

Any inclusion in genotype call

variant type common rare doubleton singleton
synonymous 11 52 21 42
disruptive 13 79 52 109
missense 11 71 45 79

PlasmoDB Total SNPs: 69

Non-coding: 42 | Synonymous: 15 | Nonsynonymous: 12 | Stop Codon: 0

Associated Publications

PMID Title Authors DOI/Link
7727509 Purification, characterization and localization of mitochondrial dihydroorotatedehydrogenase in Plasmodium falciparum, human malaria parasite. Krungkrai J 10.1016/0304-4165(94)00158-t
8232427 The dihydroorotate dehydrogenase gene homologue of Plasmodium falciparum. LeBlanc SB, Wilson CM 10.1016/0166-6851(93)90148-q
12368867 Sequence of Plasmodium falciparum chromosomes 1, 3-9 and 13. Hall N, Pain A, ..., Barrell BG 10.1038/nature01095
18225919 Analysis of flavin oxidation and electron-transfer inhibition in Plasmodiumfalciparum dihydroorotate dehydrogenase. Malmquist NA, Gujjar R, Rathod PK, Phillips MA 10.1021/bi702218c
19640844 Structural plasticity of malaria dihydroorotate dehydrogenase allows selectivebinding of diverse chemical scaffolds. Deng X, Gujjar R, ..., Phillips MA 10.1074/jbc.M109.028589
20702404 Novel inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase withanti-malarial activity in the mouse model. Booker ML, Bastos CM, ..., Sybertz E 10.1074/jbc.M110.162081
24073986 Novel selective and potent inhibitors of malaria parasite dihydroorotatedehydrogenase: discovery and optimization of dihydrothiophenone derivatives. Xu M, Zhu J, ..., Li H 10.1021/jm400938g
24782313 In vitro resistance selections for Plasmodium falciparum dihydroorotatedehydrogenase inhibitors give mutants with multiple point mutations in thedrug-binding site and altered growth. Ross LS, Gamo FJ, ..., Wirth DF 10.1074/jbc.M114.558353
25945708 The X-ray structure of Plasmodium falciparum dihydroorotate dehydrogenase boundto a potent and selective N-phenylbenzamide inhibitor reveals novel binding-siteinteractions. Deng X, Matthews D, Rathod PK, Phillips MA 10.1107/S2053230X15000989
27874068 Identification of inhibitors that dually target the new permeability pathway anddihydroorotate dehydrogenase in the blood stage of Plasmodium falciparum. Dickerman BK, Elsworth B, ..., Gilson PR 10.1038/srep37502
28435533 Discovery of Antimalarial Azetidine-2-carbonitriles That Inhibit P. falciparumDihydroorotate Dehydrogenase. Maetani M, Kato N, ..., Schreiber SL 10.1021/acsmedchemlett.7b00030
32248693 Lead Optimization of a Pyrrole-Based Dihydroorotate Dehydrogenase InhibitorSeries for the Treatment of Malaria. Kokkonda S, Deng X, ..., Phillips MA 10.1021/acs.jmedchem.0c00311
34494883 A Prioritized and Validated Resource of Mitochondrial Proteins in PlasmodiumIdentifies Unique Biology. van Esveld SL, Meerstein-Kessel L, ..., Huynen MA 10.1128/mSphere.00614-21